Health insurance company Oscar Health (NYSE:OSCR) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 23.2% year on year to $2.99 billion. On the other hand, the company’s full-year revenue guidance of $12.1 billion at the midpoint came in 0.5% above analysts’ estimates. Its GAAP loss of $0.53 per share was 6.8% below analysts’ consensus estimates.
Oscar Health (OSCR) reported mixed Q3 2025 results, missing revenue estimates but beating on EPS. The stock surged as investors focused on strong membership growth and reaffirmed full-year guidance.
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto markets.
Health insurance company Oscar Health (NYSE:OSCR) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 23.2% year on year to $2.99 billion. On the other hand, the company’s full-year revenue guidance of $12.1 billion at the midpoint came in 0.5% above analysts’ estimates. Its GAAP loss of $0.53 per share was 6.8% below analysts’ consensus estimates.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Shares of health insurance company Oscar Health (NYSE:OSCR) fell 7.8% in the afternoon session after a rival, Molina Healthcare, slashed its profit forecast, citing rising medical costs and sparking sector-wide concerns. Molina cut its 2025 adjusted profit outlook from a previous target of $19 per share to about $14, attributing the change to "unprecedented" medical claims in its ACA Marketplace plans. The company noted that competitors, including Oscar Health, faced similar cost pressures. This news caused a ripple effect across the industry, with Molina's stock plunge leading declines for other ACA-focused insurers. Oscar's shares fell as investors grew worried about the impact of these elevated costs on the company's own profitability.
Shares of health insurance company Oscar Health (NYSE:OSCR) jumped 3% in the morning session after the company announced it was expanding its health insurance coverage and introducing new AI-powered tools and specialized health plans for the 2026 open enrollment period. The company revealed its health plans would become available in 573 counties across 20 states, with new expansions into Alabama and Mississippi. To improve the customer experience, Oscar launched a personal AI agent named Oswell, powered by OpenAI, to provide members with on-demand support. The company also introduced several new offerings, including what it described as the first-ever menopause-focused plan in the individual market, called HelloMeno. The plan offered benefits such as $0 primary doctor visits and the potential for members to save up to $900 a year. A new digital rewards program, Oscar Unlocks, was also introduced to promote healthy actions.
Great things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Verizon Communications Inc. (NYSE: VZ) experienced a significant downturn in its afternoon trading session today, with its stock price falling a notable 4.8%. This abrupt decline has sent ripples through the telecommunications sector and is largely attributed to a surprise change in the company's leadership, an unexpected development that
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.
